ESC 365 - Randomized controlled trials of continued versus interrupted oral anti-coagulant at the time of device surgery: Combined analysis of BRUISE CONTROL 1 and 2

EHRA Premium Access

Randomized controlled trials of continued versus interrupted oral anti-coagulant at the time of device surgery: Combined analysis of BRUISE CONTROL 1 and 2

Session: Late-Breaking Trials

Topic: Device Complications and Lead Extraction

Speaker: Professor V. Essebag (Montreal, CA)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Vidal Essebag

McGill University Health Centre, Montreal (Canada)

2 presentations

0 follower

14 more presentations in this session

Thoracoscopic versus catheter ablation for atrial fibrillation: Long-term follow-up of the FAST randomised trial

Speaker: Professor D. Kotecha (Birmingham, GB)

Discussant review - Thoracoscopic versus catheter ablation for atrial fibrillation: Long-term follow-up of the FAST randomised trial

Speaker: Professor S. Benussi (Brescia, IT)

Panel discussion

Surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation

Speaker: Doctor A. Elvan (Braunschweig, DE)

Discussant review - Surgical versus catheter ablation for paroxysmal and early persistent atrial fibrillation

Speaker: Professor J. Kautzner (Prague, CZ)

Access the full session

Late-Breaking Trials

Speakers: Professor V. Essebag, Professor D. Kotecha, Professor S. Benussi, Doctor A. Elvan, Professor J. Kautzner

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources